Neurocrine Biosciences (NBIX) Interest & Investment Income (2010 - 2026)
Neurocrine Biosciences (NBIX) recorded Interest & Investment Income of $12.4 million in Q2 2026, down 39.8% from $20.6 million a year earlier and down 55.9% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Interest & Investment Income (2010 - 2026) Analysis & Trends
On a TTM basis, Neurocrine Biosciences' Interest & Investment Income came in at $88.5 million as of Jun 30, 2026, up 0.3% year-over-year; for FY2025, it was $90.3 million, down 0.8% from FY2024.
- Annual Interest & Investment Income has a five-year compound annual growth rate of 48.3% (FY2020 to FY2025).
- Across earlier years, Interest & Investment Income came in at $91 million in FY2024 (+72.3%), $52.8 million in FY2023, $4.1 million in FY2022 (+7.9%) and $3.8 million in FY2021 (-69.8%).
- The Q2 2026 figure is the lowest quarterly Interest & Investment Income since Q2 2023.
- On a year-over-year basis, Interest & Investment Income rose in four of the last eight quarters, with growth averaging 8.4%.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 880.0% in Q1 2023, against a decline of 75.0% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $28.1 million (Q1 2026), $25.8 million (Q4 2025) and $22.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Neurocrine Biosciences | 14.55 Bn | 10.25 Bn | 935.80 Mn | 12.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.40 Mn |
| Mar 31, 2026 | 28.10 Mn |
| Dec 31, 2025 | 25.80 Mn |
| Sep 30, 2025 | 22.20 Mn |
| Jun 30, 2025 | 20.60 Mn |
| Mar 31, 2025 | 21.70 Mn |
| Dec 31, 2024 | 22.50 Mn |
| Sep 30, 2024 | 23.40 Mn |
| Jun 30, 2024 | 22.80 Mn |
| Mar 31, 2024 | 22.30 Mn |
| Dec 31, 2023 | 18.90 Mn |
| Sep 30, 2023 | 14.50 Mn |
| Jun 30, 2023 | 10.70 Mn |
| Mar 31, 2023 | 9.80 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 1.60 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 700,000.00 |
| Sep 30, 2021 | 800,000.00 |
API Access
Neurocrine Biosciences Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();